发明授权
- 专利标题： Metabolite biomarkers for diseases associated with the contact activation system
-
申请号： US16333101申请日： 2017-09-15
-
公开(公告)号： US11340237B2公开(公告)日： 2022-05-24
- 发明人: Daniel J. Sexton , Malini Viswanathan , Ryan Faucette , Tripti Gaur
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Wolf, Greenfield & Sacks, P.C.
- 国际申请： PCT/US2017/051755 WO 20170915
- 国际公布： WO2018/053247 WO 20180322
- 主分类号： G01N33/68
- IPC分类号： G01N33/68 ; G01N33/74 ; G01N33/82 ; G01N33/92 ; G01N33/94
摘要：
Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
信息查询
IPC分类:
